Phase I and II Clinical Trial Comparing the LBSap, Leishmune® , and Leish-Tec® Vaccines against Canine Visceral Leishmaniasis

Vaccines
Rodrigo Dian de Oliveira Aguiar-SoaresAlexandre Barbosa Reis

Abstract

In this study, we performed a phase I and II clinical trial in dogs to evaluate the toxicity and immunogenicity of LBSap-vaccine prototype, in comparison to Leishmune® and Leish-Tec® vaccines. Twenty-eight dogs were classified in four groups: (i) control group received 1 mL of sterile 0.9% saline solution; (ii) LBSap group received 600 μg of Leishmania braziliensis promastigotes protein and 1 mg of saponin adjuvant; (iii) Leishmune®; and (iv) Leish-Tec®. The safety and toxicity of the vaccines were measured before and after three immunizations by clinical, biochemical, and hematological parameters. The clinical examinations revealed that some dogs of LBSap and Leishmune® groups presented changes at the site of vaccination inoculum, such as nodules, mild edema, and local pain, which were transient and disappeared seventy-two hours after vaccination, but these results indicate that adverse changes caused by the immunizations are tolerable. The immunogenicity results demonstrate an increase of B lymphocytes CD21+ regarding the Leishmune® group and monocytes CD14+ concerning LBSap and Leishmune® groups. In the in vitro analyses, an increase in lymphoproliferative activity in LBSap and Leishmune® groups was observed, with an increas...Continue Reading

References

Jul 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·C B Palatnik-de-SousaR Borojevic
Aug 27, 1999·The American Journal of Tropical Medicine and Hygiene·G P CabreraC B Palatnik-de-Sousa
Nov 22, 2002·Vaccine·Wania Renata SantosClarisa Beatriz Palatnik de Sousa
Aug 17, 2005·Veterinary Dermatology·Chiara Noli, Silvia T Auxilia
Aug 2, 2007·The Journal of Allergy and Clinical Immunology·Rosa BacchettaMaria-Grazia Roncarolo
Oct 5, 2007·Vaccine·Rodolfo Cordeiro GiunchettiAlexandre Barbosa Reis
Dec 5, 2008·Veterinary Immunology and Immunopathology·Alexandre Barbosa ReisRodrigo Corrêa-Oliveira
May 22, 2010·Trends in Parasitology·Alexandre B ReisJavier Moreno
Mar 29, 2011·Veterinary Immunology and Immunopathology·Márcio Sobreira Silva AraújoOlindo Assis Martins-Filho
Jun 14, 2012·PloS One·Jorge AlvarUNKNOWN WHO Leishmaniasis Control Team
Feb 13, 2013·Vaccine·Jacqueline Araújo FiuzaRicardo Toshio Fujiwara
Aug 21, 2013·PLoS Neglected Tropical Diseases·Danielle N C C CostaGuilherme L Werneck
Aug 31, 2013·TheScientificWorldJournal·Laila Massad RibasEduardo Massad
Oct 11, 2013·Clinical and Vaccine Immunology : CVI·Henrique Gama KerAlexandre Barbosa Reis
Dec 25, 2013·Veterinary Immunology and Immunopathology·Alexandre Barbosa ReisOlindo de Assis Martins-Filho
Jul 2, 2014·Frontiers in Immunology·Bruno Mendes RoattAlexandre Barbosa Reis
Sep 23, 2014·Veterinary Parasitology·Gleisiane Gomes de Almeida LealAlexandre Barbosa Reis
Nov 3, 2016·Veterinary Clinical Pathology·Saverio PaltrinieriEric Zini
Jun 12, 2017·Trends in Parasitology·Guadalupe MiróGaetano Oliva
Jul 12, 2017·Trends in Parasitology·Laia Solano-GallegoGad Baneth
Jul 27, 2017·Revista brasileira de parasitologia veterinária = Brazilian journal of veterinary parasitology : Órgão Oficial do Colégio Brasileiro de Parasitologia Veterinária·Diogo Tiago da SilvaWilma Aparecida Starke-Buzetti
Mar 29, 2018·Expert Review of Vaccines·Salvador IborraManuel Soto
Sep 7, 2018·PLoS Neglected Tropical Diseases·Juliana Maria Trindade BezerraMariângela Carneiro
Sep 22, 2018·Frontiers in Cellular and Infection Microbiology·Carla Maia, Lenea Campino
Feb 2, 2019·Research in Veterinary Science·Mary Marcondes, Michael J Day
Jun 20, 2019·Frontiers in Veterinary Science·Javier Moreno

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PMA
flow cytometry

Software Mentioned

Prism
FlowJo
DPP

Related Concepts